Pancreatic intra-epithelial neoplasia: Current clinicopathological and molecular considerations

Current Diagnostic Pathology

Volumn 11, Issue 2, 2005, Pages 80-94

  Andea, A A ^a   Basturk, O ^a   Adsay, N V ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Grading; Molecular; Pancreas; Pancreatic intra epithelial neoplasia; PanIN; Pre invasive

Indexed keywords

BETA CATENIN; BRCA2 PROTEIN; CYCLIN D1; CYCLIN D2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FASCIN; K RAS PROTEIN; KI 67 ANTIGEN; MESOTHELIN; MUCIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; ONCOPROTEIN; PREPROENKEPHALIN; PROSTATE STEM CELL ANTIGEN; PROTEIN 14 3 3; PROTEIN DERIVATIVE; PROTEIN P16; PROTEIN P21; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CARCINOMA IN SITU; CELL CYCLE; CLINICAL FEATURE; CONFERENCE PAPER; CYTOARCHITECTURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSPLASIA; FOLLOW UP; GENE ACTIVATION; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC DISORDER; HISTOPATHOLOGY; HISTORY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; METAPLASIA; MITOSIS; MOLECULAR BIOLOGY; NOMENCLATURE; ONCOGENE; ONCOGENE K RAS; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS INTRAEPITHELIAL NEOPLASIA; PANCREAS NECROSIS; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; REGULATOR GENE; SQUAMOUS CELL METAPLASIA; TUMOR SUPPRESSOR GENE;

EID: 13844314807     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2004.11.008     Document Type: Conference Paper

References (146)

1. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
2. B. Vogelstein, E.R. Fearon, and S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
3. S. Kern, R. Hruban, and M.A. Hollingsworth A white paper the product of a pancreas cancer think tank Cancer Res 61 2001 4923 4932
4. S.C. Sommers, S.A. Murphy, and S. Warren Pancreatic duct hyperplasias and cancer Gastroenterology 27 1954 629 640
5. A.L. Cubilla, and P.J. Fitzgerald Morphological lesions associated with human primary invasive nonendocrine pancreas cancer Cancer Res 36 1976 2690 2698
6. S. Kozuka, R. Sassa, and T. Taki Relation of pancreatic duct hyperplasia to carcinoma Cancer 43 1979 1418 1428
7. G. Klöppel, G. Bommer, and K. Ruckert Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis Virchows Arch A 387 1980 221 233
8. J. Chen, S.I. Baithun, and M.A. Ramsay Histogenesis of pancreatic carcinomas a study based on 248 cases J Pathol 146 1985 65 76
9. T. Furukawa, R. Chiba, and M. Kobari Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen Arch Pathol Lab Med 118 1994 227 234
10. R. Bentjerodt, and G. Smok Ductal epithelial lesions and pancreatic adenocarcinoma Rev Med Chile 118 1990 1099 1104
11. G. Klöppel, E. Solcia, and D. Longnecker WHO histological typing of tumours of the exocrine pancreas second ed 1996 Springer Berlin
12. R.H. Hruban, N.V. Adsay, and J. Albores-Saavedra Pancreatic intraepithelial neoplasia a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
13. D.S. Klimstra, and D.S. Longnecker K-ras mutations in pancreatic ductal proliferative lesions Am J Pathol 145 1994 1547 1550
14. D.J. Brat, K.D. Lillemoe, and C.J. Yeo Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas Am J Surg Pathol 22 1998 163 169
15. A. Andea, F. Sarkar, and V.N. Adsay Clinicopathological correlates of pancreatic intraepithelial neoplasia a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma Mod Pathol 16 2003 996 1006
16. B. Cylwik, H.F. Nowak, and Z. Puchalski Chronic pancreatitis as a predisposing factor in the development of pancreatic cancer. Histological and histochemical studies Zentralbl Allg Pathol 130 1985 217 224
17. B. Cylwik, H.F. Nowak, and Z. Puchalski Epithelial anomalies in chronic pancreatitis as a risk factor of pancreatic cancer Hepatogastroenterology 45 1998 528 532
18. T. Mukada, and S. Yamada Dysplasia and carcinoma in situ of the exocrine pancreas Tohoku J Exp Med 137 1982 115 124
19. J. Arias Perez, M.A. Aller Reyero, and L. Lorente Ruigomez [Ductal adenocarcinoma of the head of the pancreas associated pathology of body and tail] Rev Esp Enferm Apar Dig 75 1989 78 80
20. R.H. Hruban, M. Goggins, and J. Parsons Progression model for pancreatic cancer Clin Cancer Res 6 2000 2969 2972
21. R.H. Hruban, R.E. Wilentz, and M. Goggins Pathology of incipient pancreatic cancer Ann Oncol 10 Suppl. 4 1999 9 11
22. R.H. Hruban, R.E. Wilentz, and S.E. Kern Genetic progression in the pancreatic ducts Am J Pathol 156 2000 1821 1825
23. D.M. McCarthy, D.J. Brat, and R.E. Wilentz Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma analysis of progression and recurrence by DPC4 immunohistochemical labeling Hum Pathol 32 2001 638 642
24. E. Brockie, A. Anand, and J. Albores-Saavedra Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma Ann Diagn Pathol 2 1998 286 292
25. K. Takaori, Y. Kobashi, and S. Matsusue Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors J Hepatobiliary Pancreat Surg 10 2003 125 136
26. B.H. Stamm Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy a systematic study of 112 autopsies in patients without known pancreatic disease Hum Pathol 15 1984 677 683
27. P.M. Pour, S. Sayed, and G. Sayed Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases Am J Clin Pathol 77 1982 137 152
28. O. Auerbach, and L. Garfinkel Histologic changes in pancreas in relation to smoking and coffee-drinking habits Dig Dis Sci 31 1986 1014 1020
29. K. Kishi, K. Nakamura, and M. Yoshimori Morphology and pathological significance of focal acinar cell dysplasia of the human pancreas Pancreas 7 1992 177 182
30. R.H. Hruban, C. Iacobuzio-Donahue, and R.E. Wilentz Molecular pathology of pancreatic cancer Cancer J 7 2001 251 258
31. E. Rozenblum, M. Schutte, and M. Goggins Tumor-suppressive pathways in pancreatic carcinoma Cancer Res 57 1997 1731 1734
32. R.H. Hruban, G.M. Petersen, and P.K. Ha Genetics of pancreatic cancer. From genes to families Surg Oncol Clin North Am 7 1998 1 23
33. J.A. DiGiuseppe, R.H. Hruban, and G.J. Offerhaus Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma Am J Pathol 144 1994 889 895
34. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
35. C.M. Barton, S.L. Staddon, and C.M. Hughes Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 64 1991 1076 1082
36. S.Y. Zhang, B. Ruggeri, and P. Agarwal Immunohistochemical analysis of p53 expression in human pancreatic carcinomas Arch Pathol Lab Med 118 1994 150 154
37. J.A. DiGiuseppe, R.H. Hruban, and S.N. Goodman Overexpression of p53 protein in adenocarcinoma of the pancreas Am J Clin Pathol 101 1994 684 688
38. C.R. Boschman, S. Stryker, and J.K. Reddy Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas Am J Pathol 145 1994 1291 1295
39. S.A. Hahn, and S.E. Kern Molecular genetics of exocrine pancreatic neoplasms Surg Clin North Am 75 1995 857 869
40. B. Ruggeri, S.Y. Zhang, and J. Caamano Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes Oncogene 7 1992 1503 1511
41. P.S. Moore, B. Sipos, and S. Orlandini Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4 Virchows Arch 439 2001 798 802
42. P.S. Moore, S. Orlandini, and G. Zamboni Pancreatic tumours molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis Br J Cancer 84 2001 253 262
43. M.S. Redston, C. Caldas, and A.B. Seymour p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions Cancer Res 54 1994 3025 3033
44. G. Berrozpe, J. Schaeffer, and M.A. Peinado Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer Int J Cancer 58 1994 185 191
45. D. Coppola, L. Lu, and J.P. Fruehauf Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas TGF-beta1 protein expression predicts longer survival Am J Clin Pathol 110 1998 16 23
46. E.U. Lee, M.L. Cibull, and E. O'Daniel-Pierce Expression of p53 protein in pancreatic adenocarcinoma. Relationship to cigarette smoking Int J Pancreatol 17 1995 237 242
47. J. Lundin, S. Nordling, and K. von Boguslawsky Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer Oncology 53 1996 104 111
48. A. Scarpa, P. Capelli, and K. Mukai Pancreatic adenocarcinomas frequently show p53 gene mutations Am J Pathol 142 1993 1534 1543
49. E. Heinmoller, W. Dietmaier, and H. Zirngibl Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma Am J Pathol 157 2000 83 92
50. H. Kalthoff, W. Schmiegel, and C. Roeder p53 and K-RAS alterations in pancreatic epithelial cell lesions Oncogene 8 1993 289 298
51. N.S. Pellegata, F. Sessa, and B. Renault K-ras and p53 gene mutations in pancreatic cancer ductal and nonductal tumors progress through different genetic lesions Cancer Res 54 1994 1556 1560
52. S. Nakamori, K. Yashima, and Y. Murakami Association of p53 gene mutations with short survival in pancreatic adenocarcinoma Jpn J Cancer Res 86 1995 174 181
53. K. Weyrer, H. Feichtinger, and M. Haun p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas Lab Invest 74 1996 279 289
54. J. Lüttges, A. Diederichs, and M.A. Menke Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53 Cancer 88 2000 2495 2504
55. J. Lüttges, H. Galehdari, and V. Brocker Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis Am J Pathol 158 2001 1677 1683
56. A. Maitra, N.V. Adsay, and P. Argani Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray Mod Pathol 16 2003 902 912
57. P.G. Terhune, D.M. Phifer, and T.D. Tosteson K-ras mutation in focal proliferative lesions of human pancreas Cancer Epidemiol Biomarkers Prev 7 1998 515 521
58. R. Tomaszewska [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma] Folia Med Cracov 40 1999 101 141
59. R. Tomaszewska, D. Karcz, and J. Stachura An immunohistochemical study of the expression of bcl-2 and p53 oncoproteins in pancreatic intraepithelial neoplasia and pancreatic cancer Int J Pancreatol 26 1999 163 171
60. S.K. Apple, J.R. Hecht, and D.N. Lewin Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas evidence for multistep carcinogenesis Hum Pathol 30 1999 123 129
61. A.V. Biankin, J.G. Kench, and A.L. Morey Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia Cancer Res 61 2001 8830 8837
62. S. Gansauge, R.M. Schmid, and J. Muller Genetic alterations in chronic pancreatitis evidence for early occurrence of p53 but not K-ras mutations Br J Surg 85 1998 337 340
63. S.A. Hahn, M. Schutte, and A.T. Hoque DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350 353
64. J.L. Dai, K.K. Turnacioglu, and M. Schutte Dpc4 transcriptional activation and dysfunction in cancer cells Cancer Res 58 1998 4592 4597
65. J.L. Dai, M. Schutte, and R.K. Bansal Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells Mol Carcinogen 26 1999 37 43
66. J.P. de Winter, B.A. Roelen, and P. ten Dijke DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells Oncogene 14 1997 1891 1899
67. G. Lagna, A. Hata, and A. Hemmati-Brivanlou Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways Nature 383 1996 832 836
68. W. Zhou, L.J. Sokoll, and D.J. Bruzek Identifying markers for pancreatic cancer by gene expression analysis Cancer Epidemiol Biomarkers Prev 7 1998 109 112
69. E. Montgomery, M. Goggins, and S. Zhou Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects Am J Pathol 158 2001 537 542
70. M. Schutte DPC4/SMAD4 gene alterations in human cancer, and their functional implications Ann Oncol 10 Suppl. 4 1999 56 59
71. S.A. Hahn, A.T. Hoque, and C.A. Moskaluk Homozygous deletion map at 18q21.1 in pancreatic cancer Cancer Res 56 1996 490 494
72. R.E. Wilentz, G.H. Su, and J.L. Dai Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas a new marker of DPC4 inactivation Am J Pathol 156 2000 37 43
73. D. Bartsch, D.W. Shevlin, and W.S. Tung Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas Genes Chromosomes Cancer 14 1995 189 195
74. D. Bartsch, D.W. Shevlin, and M.P. Callery Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation J Natl Cancer Inst 88 1996 680 682
75. C. Caldas, S.A. Hahn, and L.T. da Costa Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
76. Y.X. Hu, H. Watanabe, and K. Ohtsubo Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma Clin Cancer Res 3 1997 1473 1477
77. L. Huang, T.L. Goodrow, and S.Y. Zhang Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas Cancer Res 56 1996 1137 1141
78. M. Naumann, N. Savitskaia, and C. Eilert Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors Gastroenterology 110 1996 1215 1224
79. M. Schutte, R.H. Hruban, and J. Geradts Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126 3130
80. A. Merlo, J.G. Herman, and L. Mao 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 1995 686 692
81. T. Ueki, M. Toyota, and T. Sohn Hypermethylation of multiple genes in pancreatic adenocarcinoma Cancer Res 60 2000 1835 1839
82. J. Geradts, R.H. Hruban, and M. Schutte Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies Appl Immunohistochem Mol Morphol 8 2000 71 79
83. R.E. Wilentz, J. Geradts, and R. Maynard Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions loss of intranuclear expression Cancer Res 58 1998 4740 4744
84. N. Fukushima, N. Sato, and T. Ueki Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma Am J Pathol 160 2002 1573 1581
85. C. Rosty, J. Geradts, and N. Sato p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis Am J Surg Pathol 27 2003 1495 1501
86. H. Ozcelik, B. Schmocker, and N. Di Nicola Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1997 17 18
87. M. Goggins, M. Schutte, and J. Lu Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 1996 5360 5364
88. K.W. Kinzler, and B. Vogelstein Cancer-susceptibility genes. Gatekeepers and caretakers Nature 386 1997 761 763
89. M. Goggins, R.H. Hruban, and S.E. Kern BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia evidence and implications Am J Pathol 156 2000 1767 1771
90. D.D. De Vries, L.N. Went, and G.W. Bruyn Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia Am J Hum Genet 58 1996 703 711
91. R.H. Hruban, A.D. van Mansfeld, and G.J. Offerhaus K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization Am J Pathol 143 1993 545 554
92. M. Mariyama, K. Kishi, and K. Nakamura Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients Jpn J Cancer Res 80 1989 622 626
93. K. Motojima, T. Urano, and Y. Nagata Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma Ann Surg 217 1993 138 143
94. A. Scarpa, P. Capelli, and A. Villaneuva Pancreatic cancer in Europe Ki-ras gene mutation pattern shows geographical differences Int J Cancer 57 1994 167 171
95. V.T. Smit, A.J. Boot, and A.M. Smits KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas Nucleic Acids Res 16 1988 7773 7782
96. C. Almoguera, D. Shibata, and K. Forrester Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
97. J. Lüttges, B. Schlehe, and M.A. Menke The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium Cancer 85 1999 1703 1710
98. C.A. Moskaluk, R.H. Hruban, and S.E. Kern p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140 2143
99. M. Tada, M. Ohashi, and Y. Shiratori Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease Gastroenterology 110 1996 227 231
100. M. Tada, M. Omata, and S. Kawai Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Res 53 1993 2472 2474
101. B. Gerdes, A. Ramaswamy, and B. Simon Analysis of beta-catenin gene mutations in pancreatic tumors Digestion 60 1999 544 548
102. C.A. Iacobuzio-Donahue, A. Maitra, and M. Olsen Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 2003 1151 1162
103. S.C. Abraham, T.T. Wu, and R.H. Hruban Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway Am J Pathol 160 2002 953 962
104. S.C. Abraham, T.T. Wu, and D.S. Klimstra Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas frequent alterations in the APC/beta-catenin pathway and chromosome 11p Am J Pathol 159 2001 1619 1627
105. S.C. Abraham, D.S. Klimstra, and R.E. Wilentz Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations Am J Pathol 160 2002 1361 1369
106. S. Gansauge, F. Gansauge, and M. Ramadani Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis Cancer Res 57 1997 1634 1637
107. M. Kornmann, T. Ishiwata, and J. Itakura Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival Oncology 55 1998 363 369
108. B. Poch, F. Gansauge, and A. Schwarz Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma evidence for a cyclin D1-dependent cell cycle progression Pancreas 23 2001 280 287
109. M. Kornmann, N. Arber, and M. Korc Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum J Clin Invest 101 1998 344 352
110. H. Matsubayashi, N. Sato, and N. Fukushima Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues Clin Cancer Res 9 2003 1446 1452
111. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
112. J. LaBaer, M.D. Garrett, and L.F. Stevenson New functional activities for the p21 family of CDK inhibitors Genes Dev 11 1997 847 862
113. J.A. DiGiuseppe, M.S. Redston, and C.J. Yeo p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma Am J Pathol 147 1995 884 888
114. S. Linder, C. Parrado, and U.G. Falkmer Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material Br J Cancer 76 1997 54 59
115. K. Makinen, T. Hakala, and P. Lipponen Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma Anticancer Res 18 1998 615 618
116. W.M. Klein, R.H. Hruban, and A.J. Klein-Szanto Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN) additional evidence for a recently proposed model of progression Mod Pathol 15 2002 441 447
117. Y.S. Kim, J. Gum Jr, and I. Brockhausen Mucin glycoproteins in neoplasia Glycoconj J 13 1996 693 707
118. Y.S. Kim, J.R. Gum Jr, and S.C. Crawley Mucin gene and antigen expression in biliopancreatic carcinogenesis Ann Oncol 10 Suppl. 4 1999 51 55
119. M.A. Hollingsworth, J.M. Strawhecker, and T.C. Caffrey Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines Int J Cancer 57 1994 198 203
120. Y. Li, and D. Kufe The human DF3/MUC1 carcinoma-associated antigen signals nuclear localization of the catenin p120(ctn) Biochem Biophys Res Commun 281 2001 440 443
121. Y. Makiguchi, Y. Hinoda, and K. Imai Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth Jpn J Cancer Res 87 1996 505 511
122. S. Satoh, Y. Hinoda, and T. Hayashi Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule Int J Cancer 88 2000 507 518
123. T. Terada, T. Ohta, and M. Sasaki Expression of MUC apomucins in normal pancreas and pancreatic tumours J Pathol 180 1996 160 165
124. J.C. Byrd, J.J. Ho, and D.T. Lamport Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins Cancer Res 51 1991 1026 1033
125. A. Allen, D.A. Hutton, and J.P. Pearson The MUC2 gene product a human intestinal mucin Int J Biochem Cell Biol 30 1998 797 801
126. N.V. Adsay, K. Merati, and O. Basturk Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms delineation of an 'intestinal' pathway of carcinogenesis in the pancreas Am J Surg Pathol 28 2004 839 848
127. N.V. Adsay, K. Merati, and H. Nassar Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas Am J Surg Pathol 27 2003 571 578
128. N.V. Adsay, K. Merati, and A. Andea The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis Mod Pathol 15 2002 1087 1095
129. N.V. Adsay, C. Pierson, and F. Sarkar Colloid (mucinous noncystic) carcinoma of the pancreas Am J Surg Pathol 25 2001 26 42
130. H.U. Park, J.W. Kim, and G.E. Kim Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia Pancreas 26 2003 e48 e54
131. J.J. Ho, S.W. Han, and P.L. Pan Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells Int J Oncol 22 2003 273 279
132. G.E. Kim, H.I. Bae, and H.U. Park Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas Gastroenterology 123 2002 1052 1060
133. I.S. Zagon, C.D. Roesener, and M.F. Verderame Opioid growth factor regulates the cell cycle of human neoplasias Int J Oncol 17 2000 1053 1061
134. T. Ueki, M. Toyota, and H. Skinner Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma Cancer Res 61 2001 8540 8546
135. K. Satoh, H. Sasano, and T. Shimosegawa An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas Cancer 72 1993 51 56
136. P.A. Hall, C.M. Hughes, and S.L. Staddon The c-erb B-2 proto-oncogene in human pancreatic cancer J Pathol 161 1990 195 200
137. J.D. Day, J.A. Digiuseppe, and C. Yeo Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms Hum Pathol 27 1996 119 124
138. C.A. Iacobuzio-Donahue, A. Maitra, and G.L. Shen-Ong Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol 160 2002 1239 1249
139. B. Ryu, J. Jones, and M.A. Hollingsworth Invasion-specific genes in malignancy serial analysis of gene expression comparisons of primary and passaged cancers Cancer Res 61 2001 1833 1838
140. B. Ryu, J. Jones, and N.J. Blades Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression Cancer Res 62 2002 819 826
141. P. Argani, C. Rosty, and R.E. Reiter Discovery of new markers of cancer through serial analysis of gene expression prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma Cancer Res 61 2001 4320 4324
142. A. Maitra, C. Iacobuzio-Donahue, and A. Rahman Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays sea urchin fascin homolog and heat shock protein 47 Am J Clin Pathol 118 2002 52 59
143. P. Argani, C. Iacobuzio-Donahue, and B. Ryu Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) Clin Cancer Res 7 2001 3862 3868
144. F. Khanani, O. Basturk, and F. Sarkar P63 expression in pancreas and pancreatic neoplasms a reliable marker for distinguishing squamous/transitional metaplasia from pancreatic intraepithelial neoplasia Mod Pathol 17 2004 304A
145. R.H. Hruban, K. Takaori, and D.S. Klimstra An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
146. R.E. Wilentz, C.A. Iacobuzio-Donahue, and P. Argani Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia evidence that DPC4 inactivation occurs late in neoplastic progression Cancer Res 60 2000 2002 2006